SGMOQ (SGMOQ) Stock Price & Analysis
SGMOQ (SGMOQ) fell 5.88% to USD 0.16 as of September 8, 2026 at 09:37 UTC, according to Nexqual real-time market data.
SGMOQ last closed at USD 0.16; the session ranged USD 0.16–0.17 on volume of 760,758 shares. Market capitalization is —, with a 52-week range of USD 0.03–0.77 (PNK). Source: Nexqual, September 8, 2026 at 09:37 UTC.
Key Statistics (as of September 8, 2026 at 09:37 UTC)
| Price | USD 0.16 |
|---|---|
| Change | ▼ 5.88% (down) |
| Previous Close | USD 0.16 |
| Open | USD 0.16 |
| Day Range | USD 0.16 – 0.17 |
| 52-Week Range | USD 0.03 – 0.77 |
| Volume | 760,758 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (SGMOQ)
Nexqual's technical model rates SGMOQ "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 09:37 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 62.36 (neutral) |
| vs SMA50 | Above (USD 0.11) |
| MACD | 0.01 (positive) |
From SGMOQ's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EDIT | Editas Medicine, Inc. | USD 3.23 | ▲ 4.87% |
| NTLA | Intellia Therapeutics, Inc. | USD 12.74 | ▼ 0.16% |
| NKTR | Nektar Therapeutics | USD 74.19 | ▲ 1.99% |
| ALNY | Alnylam Pharmaceuticals, Inc. | USD 266.11 | ▼ 0.48% |
| CLLS | Cellectis S.A. | USD 3.24 | ▼ 0.31% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:37 UTC. This page is informational and not investment advice.